{
  "@type": "dcat:Dataset",
  "accessLevel": "public",
  "accrualPeriodicity": "R/P1Y",
  "bureauCode": [
    "009:10"
  ],
  "contactPoint": {
    "@type": "vcard:Contact",
    "fn": "Division of Drug Information",
    "hasEmail": "mailto:druginfo@fda.hhs.gov"
  },
  "description": "Thallous Chloride Tl 201 is a radioactive diagnostic agent used for myocardial perfusion imaging to assess heart blood flow and function. It is administered intravenously as an injection solution. This information was generated using AI and is provided for informational and research purposes only.",
  "distribution": [
    {
      "@type": "dcat:Distribution",
      "description": "\n        Access the FDA dataset for Thallous chloride, tl 201 — ANDA 018150 submitted by Mylan Institutional LLC\n    ",
      "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018150",
      "mediaType": "text/html",
      "title": "Thallous chloride, tl 201"
    }
  ],
  "identifier": "ANDA018150",
  "issued": "2016-09-16",
  "keyword": [
    "drug",
    "drug-manufacturers",
    "medications",
    "pharmaceuticals",
    "prescription-drugs"
  ],
  "landingPage": "https://www.fda.gov/drugs",
  "license": "https://open.fda.gov/license",
  "modified": "2025-03-17",
  "programCode": [
    "009:002"
  ],
  "publisher": {
    "@type": "org:Organization",
    "name": "U.S. Food and Drug Administration"
  },
  "theme": [
    "FDA"
  ],
  "title": "Thallous chloride, tl 201"
}